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Abstract 
Aims: This study evaluated; A) global right ventricular (RV) phenotype in endurance vs. 
resistance trained male athletes; B) the impact of scaling for body size on the interpretation 
of RV structural data, and c) regional RV function using modern imaging technologies. 
Methods: A prospective cross-sectional design assessed the RV in 19 elite endurance-
trained (ET), 21 elite resistance-trained (RT) and 21 sedentary control (CT) participants. 
Standard 2D, tissue-Doppler imaging (TDI) and speckle tracking echocardiography (STE) 
assessed RV structure and function. Indexing of RV structural parameters to body surface 
area (BSA) was undertaken using allometric scaling. Results: A higher absolute RV diastolic 
area was observed in ET (mean ± SD: 27 ± 4 cm2) compared to CT (22 ± 4 cm2; P<0.05) that 
was maintained after scaling.  There was no difference between CT and RT (24 ± 4 cm2; 
P>0.05). Whilst absolute RV longitudinal dimension was greater in ET (88 ± 9 mm) than CT 
(81 ± 10 mm; P<0.05) this difference was removed after scaling. There were no between 
group differences in global or regional RV function. Conclusion: ET athletes presented with 
some structural characteristics of an athletic heart but the RV in RT athletes was not 
different to CT. Scaling can impact structural data interpretation in the RV of athletes. 
Global and regional RV function was not altered in athletes.  These data should be taken 
into account when discriminating the athlete’s heart from pathology during screening.  
Abstract 236 (Max 250) 
Word count 3,015 (Max 3,000) 
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INTRODUCTION  
Regular intense sporting activity can lead to physiological hypertrophy of the left 
ventricle (LV) that was initially proposed to be training dependent (Morganroth et al. 1975). 
The training-dependent dichotomous athletic heart phenotype was linked to differential 
haemodynamic loading during acute exercise (George et al. 1991) resulting in eccentric 
hypertrophy (balanced increase in chamber and wall dimension) with endurance training 
(ET) versus concentric hypertrophy (disproportionate increase in wall thickness) with 
resistance training (RT).  Recent evidence from individual studies and meta-analysis 
supports the existence of an athletic heart in ET but casts doubt over the degree of 
adaptation in RT (Haykowsky et al. 2000, Utomi et al. 2013, Utomi et al. 2014). 
Whether the right ventricle (RV) demonstrates a training-dependent athletic heart 
phenotype has received less attention (Utomi et al. 2013).  This may be partially due to the 
complexity of non-invasive imaging of the RV but technological advancements have resulted 
in the establishment of standardised assessment protocols for the RV (Rudski et al. 2010). 
This has prompted renewed interest in the RV of athletes and the ability to differentiate RV 
physiological hypertrophy from pathological changes associated with hereditary diseases 
such as arrhythmogenic RV cardiomyopathy (ARVC) that may increase the risk of sudden 
cardiac death (Maron et al. 2007).   
A small number of studies have described greater RV structural parameters in ET 
athletes compared to controls (Baggish et al. 2008, Teske et al. 2009b, D'Andrea et al. 2013) 
but limited evidence has assessed the impact of different training focus on the RV   (Koc et al 
2007, D'Andrea et al. 2013, Pagourelias et al. 2013, King et al. 2013). In addition it is well 
established that taking into account differences in body size and composition can alter the 
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interpretation of LV athletic heart data (Dewey et al. 2008) but little attention has been 
given to the scaling of RV dimensions (Oxborough et al. 2012).  This is, however, important 
in any RV data interpretation and could have implications for improving the sensitivity and 
specificity of existing upper normal limits for RV dimensions (Marcus et al. 2010).  
Finally, available global and regional functional data in the RV of athletes is also 
limited. RV ε data in athletes are controversial with reduced resting deformation in some 
(Teske et al. 2009a, King et al. 2013, La Gerche et al. 2012) but not all studies (Oxborough et 
al. 2012, Pagourelias et al. 2013). Given the potential value of deformation parameters to 
improve the discrimination of normal and pathologic adaptation (Teske et al. 2009a, Marcus 
et al. 2010) further evaluation in a different athlete groups will be unique. 
This study tests the hypotheses that; 1) global RV adaptation to exercise is mediated 
by training type; 2) the scaling of RV structural data will alter data interpretation, and 3) 
global and regional RV function will be training-type dependent.   
 
METHODS 
Study population 
After the approval of the institutional ethics committee, 61 males provided written 
informed consent to participate in the study. Participants were recruited by direct contact 
with individuals, athletes, coaches and event organizers. Inclusion and exclusion criteria 
were as follows. We recruited elite athletes (competitive at a national or international 
level).  Specifically, 19 were elite endurance (ET) athletes recruited from an international 
field at the Western States 100 miles endurance run (California, USA), 21 were elite 
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resistance trained (RT) athletes recruited from the British national weightlifting and Aikido 
squad. The ET and RT were matched for accumulated mean training years, training hours 
per week and training days per week of (ET: 11 yr, 12 hours/wk and 6 days/wk; RT: 12 yr, 11 
hours/wk, 6 days/wk, respectively). All athletes reported a minimum of 6 years continuous 
national and international level participation and were competing at the highest 
competitive sporting level in their respective specialties. In addition, 21 sedentary controls 
(CT) were recruited from the university student population in a similar age range. The CT 
were healthy individuals who were not engaged in systematic sport-related training and 
engaged in less than 3 hours recreational activity per week. All participants self-reported as 
healthy, free from known cardiovascular disease and were not currently taking any form of 
prescribed medication.  All participants were Caucasian, non-smokers, between the ages 18-
45 and reported no early family history of cardiovascular disease. The study was guided by 
the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) 
Statement: guidelines for reporting observational studies (see checklist) (von Elm E et al. 
2008) and conformed to the standards set by the Declaration of Helsinki. The demographic 
characteristics of all participants are presented in Table 1.  
Study Design and Procedures 
A prospective cross-sectional study design was employed with data acquired in a 
resting state at a single testing session. All subjects were advised to abstain from exercise 
training, caffeine and alcohol consumption at least 3 hours prior to the investigation. After a 
detailed explanation of the test protocol, subjects were initially issued with a medical 
questionnaire and then assessed for basic anthropometrics.  Height and body mass were 
assessed using a stadiometer and digital weighing machine (SECA 764, Birmingham, UK.) 
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and body surface area (BSA) was calculated. After 5 minutes of supine rest, brachial artery 
systolic and diastolic blood pressures as well as resting heart rate were assessed with an 
automated sphygmomanometer (DINAMAP 300, GE Medical Systems, Milwaukee, 
Wisconsin).  
Echocardiographic Assessment 
Standard echocardiographic investigation was performed using a Vivid Q ultrasound 
machine (GE Medical System, Horten, Norway) with a 2.5-5 MHz transducer. All acquisitions 
were made with the subject lying in the left lateral decubitus position by the same 
experienced echocardiographer (DO) using a standard echo-protocol in accordance with the 
American Society of Echocardiography (ASE) (Lang et al. 2005). Standard 2D 
echocardiographic parameters were obtained from parasternal and modified apical acoustic 
windows (Rudski et al. 2010). Images were recorded to DVD in a raw Digital Imaging and 
Communications in Medicine (DICOM) format. Further offline analysis was performed using 
commercially available software (EchoPAC Version 7.0; GE Vingmed Ultrasound, Horten, 
Norway).   
Conventional 2D and Doppler / Tissue Doppler 
In accordance with ASE guidelines, RV size was measured at end-diastole from the 
proximal out flow tract (RVOT) using a parasternal short-axis (PSAX) orientation at the level 
of the aortic valve and at the basal RV inflow (RV1) from a modified apical 4-chamber 
orientation. RV length (RVL) was also measured from the RV apex to the tricuspid annulus 
(RVD3). RV diastolic and systolic areas were calculated by tracing around the endocardium 
from a modified apical 4-chamber orientation, and RV fractional area change was calculated 
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(Rudski et al. 2010). All RV structural variables were allometrically scaled for individual 
differences in BSA according to laws of geometric similarity (Dewey et al. 2008).Colour TDI 
was used to assess RV myocardial velocities. Standard colour Doppler tissue imaging 
acquisition was undertaken with a temporal resolution >150 framesec-1 . Offline analysis 
allowed a 6 x 6mm sample volume to be placed in the tricuspid annulus of the RV lateral 
wall and peak velocities in systole (RVS’) and early diastole (RVE’) and late diastole (RVA’) to 
be measured.  Tissue velocity data were scaled to RV length (Oxborough et al. 2012).  
Speckle Tracking echocardiography (STE) 
The apical 4-chamber orientation was used for the assessment of longitudinal RV ԑ 
and SR. During off-line analysis, the region of interest was placed around the RV lateral wall 
from the base to apex. Global peak values were obtained as the average of the base, mid 
and apical wall segments to determine a basal-to-apex gradient. Indices obtained included 
peak RV ԑ and SR during ventricular systole (SRS) and during early and late ventricular 
diastole (SRE and SRA).  Intra-observer variation for RV structural and functional data were 
analysed in our laboratory on 20 subjects with two separate acquisitions to achieve a within-
participant, within day design (Oxborough et al. 2012). No systematic bias was 
demonstrated for peak ε or indices of SR (P < 0.05). The ICCs and CoVs for peak ε and peak 
SR parameters were 0.834 and 0.610 and 7% and 13% respectively. 
 
Data Analysis and Statistics 
All the analysis were performed using SPSS, version 20.0, for Windows (SPSS, 
Chicago, IL, USA) and the critical alpha was set at p ≤ 0.05. Absolute data were extracted 
from DICOM file format. Data are presented as mean ± SD, and were analysed between 
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groups using one-way ANOVA and Bonferoni post hoc test for multiple comparison to 
estimate differences between groups. A sample size ≥ 15 from each target population (CT, 
ET and RT) was prospectively determined to achieve 80% statistical power, accommodate 
data variability in the study population and detect a 3 mm differences in LV chamber 
dimension between groups.  
 
RESULTS 
Demographic characteristics of the study population 
The three groups were comparable for body mass, height, BSA and resting blood 
pressure (Table 1). ET athletes were older than CT as well as having a lower resting HR 
compared to RT.  
 Insert Table 1. 
2D-Echocardiography: RV structure 
RV structural data (absolute and allometrically scaled) are contained in Table 2. 
Higher absolute values for RVD1, RVD3, RV area (diastolic and systolic) and RV free wall 
thickness were observed in the ET compared to CT. Absolute RVD1 was also higher in ET 
than RT.  When these variables were scaled allometrically, all remained significant except 
RVD3 (between ET and CT) and RVD1 (between ET and RT). There were no differences in 
absolute or scaled RV structural data between RT and CT. Table 3 shows the % of subjects in 
each group that fulfilled the major and minor ASE Taskforce Criteria for the diagnosis of 
ARVC.  
Insert Table 2 and 3 
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Global and Regional RV Function 
Global RV functional data are presented in Table 4. There was no statistically 
significant difference (p<0.05) in standard RV functional parameters between all groups. 
Global RV ԑ, SRS as well as segmental ԑ did not significantly differ between the three groups. 
The base-to-apex gradient for ε was not different between groups (Table 5). 
Insert Table 4 and 5. 
 
DISCUSSION  
The key findings from this study were; 1) evidence that RV chamber and wall thickness were 
greater in ET compared to CT but with no differences noted between RT and CT, 2) that the 
scaling or indexation of RV structural data for individual differences in BSA can significantly 
alter data interpretation, and 3) both global and regional RV function were similar in all 
groups.  
RV Morphology 
This study provides additional evidence that physiological remodelling can occur in 
the RV of ET athletes. Overall, the higher RV diameters and areas in ET athletes support 
previous studies (Oxborough et al. 2012, D'Andrea et al. 2013).  D’ Andrea et al (2013) 
reported an RVD1 (38.1±5.3 [32–45]) mm in ET which compares favourably to the current 
data (45 ± 5 [39:57]). Cross-sectional athlete data were supported by a prospective study of 
ET athletes (Baggish et al. 2008), where a progressive increase in training load over 12 
weeks resulted in evidence of RV dilatation.  A greater RV wall thickness was also observed 
in the ET compared to CT (Koç et al. 2007, King et al. 2013). The putative mechanism(s) 
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involved in RV adaptation to ET remain controversial and poorly understood.  
Haemodynamic theories of adaptation previously applied to the LV have been purported to 
play a similar role in the RV such that ET activity places a prolonged but intermittent 
haemodynamic volume overload that initiates structural adaptation to normalise wall stress 
(Grossman et al. 1975). Recently, La Gerche et al (2011) demonstrated that a 
disproportionate haemodynamic afterload is placed on the RV, compared with the LV, 
during intense ET due to a greater relative increase in pulmonary artery systolic pressure 
(PASP) (LaGerche et al. 2011). This may partially explain the increase RV wall thickness data 
in the ET athletes.  
Of note in the current study was the lack of difference in RV structural data between 
RT and CT, especially in relation to wall thickness. This lack of adaptation mirrors recent 
reports (D'Andrea et al. 2013, King et al. 2013, Pagourelias et al. 2013) and athlete-control 
cross-sectional examination of the LV (Utomi et al. 2014). The lacks of RV adaptation in RT 
athletes agrees with prospective data collected before and after a progressive increase in RT 
load (Baggish et al. 2008).  Potential reasons for the lack of adaptation in the RV of elite RT 
athletes may relate to the limited time exposure to any haemodynamic overload, compared 
to the long-term steady state haemodynamic conditions associated with endurance training 
and/or the lack of any significant haemodynamic pressure overload stimulus in the presence 
of a Valsalva manoeuvre (Haykowsky et al. 2001).   
The present study also demonstrated that when absolute structural data for the RV 
are indexed or scaled for individual differences in body size (here BSA) alterations in 
between group comparisons can occur which fundamentally change data interpretation. 
Whilst not a consistent affect across all variables, this should be noted carefully as it may 
well impact clinical data interpretation.  The importance of body size on cardiac dimension 
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has been demonstrated in empirical studies (George et al. 1998, Utomi et al. 2014) and has 
been highlighted in review articles (Dewey et al. 2008) and a recent meta-analysis (Utomi et 
al. 2013). The current data add to this knowledge base specifically with respect to the 
interpretation of RV data in athletes but further work should produce normative data for 
large athlete groups using this allometric approach. 
 
Global and Regional RV Function 
Similar to study by King et al (2013), RV FAC and TAPSE as well as a range of other 
global parameters were not different between ET, RT and CT. Conversely, Teske et al (2009) 
reported higher TAPSE in ET (26.0 ± 4.7 mm) than CT (24.1 ± 2.6 mm). Heterogeneity 
between studies may be due to differences in age, training levels, echocardiographic 
window and non-uniformity of echo vendor algorithms.   As with global systolic function we 
observed no between group differences in RV diastolic Doppler-flow parameters which 
confirms some past work (Prakken et al. 2010, Oxborough et al. 2012, Pagourelias et al. 
2013) but disagrees with Teske et al (2009). Other studies have suggested some differences 
between ET and CT (Teske et al. 2009b). Overall there seems to be little evidence to support 
training induced changes in global RV systolic and diastolic function, including prospective 
data from Baggish et al (2008), and this would suggest that at rest cardiac function remains 
normal in athletes.  
In addition to global function we observed no between group differences in regional 
RV function using tissue-Doppler and STE. This confirms previous TDI data in athlete-control 
comparisons (Pela et al. 2004, Krol et al. 2011, D'Andrea et al. 2013). Of note global and 
regional longitudinal RV Ԑ and SR were not different between groups and were also not 
diminished in any athletes meeting the ARVC ASE revised Task Force criteria (Marcus et al. 
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2010). This observation contrasts the report by Teske et al. (2009) who demonstrated that Ԑ 
and SR of the RV free wall were reduced in 63 highly trained athletes relative to controls, 
particularly in the basal segments of athletes with RV dilatation. The authors proposed that 
this reflected normal physiological adaptation that resulted in a base-to-apex gradient in RV 
deformation (Teske et al. 2009b).  Whilst we observed a base-to-apex gradient in 
deformation, this was not different between all groups. It is speculated that because RV 
volume is greatest at the base, a smaller degree of deformation may be required to 
generate the same stroke volume, if contractility is preserved which consequently produces 
a base-to-apex gradient (La Gerche et al. 2012). It is also possible that any functional 
adaptation in the athletic heart is not apparent at rest, but may be noticeable during 
exercise (Utomi et al. 2014). Further assessment of global and regional RV function at peak 
exercise could provide further insight to allow for distinction between athletes, control 
participants and those with RV pathology. 
 
Clinical Implications: The ASE revised criteria for the diagnosis of ARVC 
We applied the revised Task force diagnostic criteria for ARVC (Marcus et al. 2010) to 
RV data in all groups. Major and minor criteria were observed in all groups but generally the 
higher percentages occurred in ET athletes.  The highest prevalence of criteria reached was 
for RVOT dimension measured in the PLAX, with lower expression in the PSAX suggesting 
that imaging window should be taken into account in any data interpretation.  In 50% of ET, 
absolute PLAX RVOT fulfilled the major echocardiographic diagnostic criteria (≥ 32 mm) and 
16% met the minor criteria (≥ 29 mm but ≤ 32 mm) for ARVC/D, although when this data 
were scaled (ratio) to BSA the prevalence dropped markedly and again reflects the 
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importance of scaling RV structural data. These findings are consistent with previous reports 
by our group (Oxborough et al 2012b) and others (Teske et al. 2009b, Prakken et al. 2010). 
The important point, from a clinical perspective is that no individual participant met either 
the major or minor ARVC criteria of poor RV function. Given that in the early concealed 
phase of ARVC, individuals are often asymptomatic but may nonetheless be at risk of 
sudden cardiac death (Maron and Pelliccia 2006 , Marcus et al. 2010), continued research in 
this area is suggested.     
 
Limitations and Future Research 
This was a cross-sectional study in small but highly trained cohorts of male Caucasian 
athletes. Further work should expand the participant base as well as development of a 
prospective cohort designs. Although STE is independent of angle of isonation, issues with 
reverberation and drop out artefact can result in low signal-to-noise ratios and 
uninterpretable data. Future studies should describe the upper limits of atrial structure and 
function in elite athlete groups as well as develop data on the acute exercise response of 
cardiac function in the athletic heart. 
 
Conclusion 
This study observed increased RV dimensions in elite ET athletes compared to CT 
with no evidence of physiological RV hypertrophy in RT athletes.  Most of the ET met at least 
one major or minor criteria for ARVC but this data, as well as statistical between group 
comparisons, were ameliorated by scaling or indexing of absolute data. Global and regional 
RV function was not different between both athlete group and CT.   
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Table 1: Demographic data of male endurance-trained (ET), resistance-trained (RT) and 
sedentary control (CT) subjects. 
Parameter ET RT CT 
Sample Size 19 21 21 
Age                                  
(years) 
34 ± 5 [23:41]† 29 ± 8 18:44] 27 ± 8 [20:43] 
Body Mass                             
(kg) 
74 ± 9 [59:87] 83 ± 14 [61:111] 76 ± 10 [61:91] 
Height                                
(m) 
1.8 ± 0.1 [1.5:1.9] 1.8 ± 0.1 [1.7:1.9] 1.8 ± 0.1 [1.6:1.9] 
BSA                                   
(kg/m2) 
2.1 ± 0.2 [1.7:2.4] 2.3 ± 0.3 [1.8:2.9] 2.1 ± 0.2 [1.7:2.5] 
Resting Heart Rate 
(beats/min) 
56 ± 11 [40:80]‡ 70 ± 11 [56:98] 63 ± 10 [53:84] 
Resting Systolic BP 
(mmHg) 
130 ± 10 [110:140] 131 ± 9 [110:141] 128 ± 12 [105:140] 
Resting Diastolic BP 
(mmHg) 
78 ± 11 [58:90] 76 ± 7 [59:89] 75 ± 8 [59:89] 
Data are mean ± SD with [range]. 
BSA – Body surface area; † P<0.05 versus CT and ‡ p< 0.05 versus RT.  
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Table 2: Absolute and allometrically scaled right ventricular structural data in male 
endurance-trained (ET), resistance-trained (RT) and sedentary control (CT) subjects.  
Parameter ET RT CT 
RVOT PLAX (mm) 31 ± 4 [23:37] 29 ± 4 [22:35] 30 ± 4 [23:38] 
RVOT PLAX  (mm/[m2]0.5) 21 ± 3 [17:26] 20 ± 3 [16:24] 21 ± 2 [17:25] 
RVOT1 (mm) 32 ± 5 [24:40] 31 ± 5 [22:42] 32 ± 3 [23:36] 
RVOT1 (mm/[m2]0.5) 22 ± 3 [18:27] 21 ± 3 [16:25] 22 ± 3 [17:27] 
RVOT2 (mm) 27 ± 5 [22:39] 25 ± 3 [20:32] 26 ± 3 [20:31] 
RVOT2 (mm/[m2]0.5) 19 ± 3 [17:20] 17 ± 2 [16:18] 18 ± 2 [17:20] 
RVD1 (mm) 45 ± 5 [39:57]†‡ 40 ± 5 [32:51] 39 ± 4 [31:45] 
RVD1  (mm/[m2]0.5) 31 ± 4 [26:42]† 28 ± 4 [20:33] 27 ± 3 [22:33] 
RVD2 (mm) 30 ± 3 [25:35] 30 ± 4 [24:38] 29 ± 3 [20:32] 
RVD2 (mm/[m2]0.5) 21 ± 2 [20:22] 20 ± 3 [19:21] 20 ± 2 [19:21] 
RVD3 (mm) 88 ± 9 [72:106]† 84 ± 10 [69:102] 81 ± 10 [64:98] 
RVD3 (mm/[m2]0.5) 61 ± 5 [58:64] 56 ± 7 [54:59] 56 ± 7 [53:60] 
RV diastolic area (cm2) 27 ± 4 [23:35]† 24 ± 5 [17:36] 22 ± 4 [15:29] 
RV diastolic area (cm2/m2) 19 ± 3 [16:26]† 16 ± 4 [11:24] 15 ± 3 [10:20] 
RV systolic area (cm2) 14 ± 2 [10:18]† 13 ± 3 [8:18] 11 ± 3 [7:18] 
RV Systolic area (cm2/m2)  9 ± 2 [7:13]† 8 ± 2 [5:13] 7 ± 2 [5:13] 
RV wall thickness (mm) 4 ± 1 [3:5]† 4 ± 1 [3:5]  3 ± 1 [2:4] 
RV wall thickness (mm/[m2]0.5) 2.8 ± 0.4 [2.1:3.2]† 2.3 ± 0.4 [1.1:3.1] 2.1 ± 0.5 [1:3]  
Data are mean ± SD with [range]. 
RV-Right ventricle, RVOT PLAX-RV outflow tract dimension parasternal long axis anterior 
portion, RVOT1-basal parasternal short axis, RVOT2-distal parasternal short axis at 
pulmonary bifurcation, RVD1-RV basal dimension, RVD2-mid cavity dimension, RVD3-RV 
longitudinal dimension, RV diastolic area-RV area at end-diastole,  † p<0.05 versus CT and ‡ 
P<0.05 versus RT.  
 
 
  
20 
 
Table 3: Percentage of participants in each group who meet specific ASE revised task force 
criteria for diagnosis of ARVC (Marcus et al 2010). 
Parameters ET RT CT 
 
M
aj
o
r 
PLAX RVOT ≥ 32 mm 50 31 23 
PLAX RVOT/BSA ≥ 19mm 6 0 0 
PSAX RVOT ≥ 36 mm 27 5 28 
PSAX RVOT/BSA ≥ 21 mm/m2 0 0 0 
FAC ≤ 33% 0 0 0 
 
M
in
o
r 
PLAX RVOT ≥ 29 mm but <  32 mm 16 23 19 
PLAX RVOT/BSA ≥ 16 but < 19 mm/m2 28 13 19 
PSAX RVOT ≥ 36 mm but <  36 mm 22 43 24 
PSAX RVOT/BSA  ≥ 18 but < 21 mm 28 14 19 
FAC ≤ 40% but >  33% 0 0 0 
 
ASE-American Society of Echocardiography, PSAX-parasternal short axis, BSA-body surface 
area and FAC-fractional area change.  
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Table 4: Right ventricular functional data in male endurance-trained (ET), resistance-trained 
(RT) and sedentary control (CT) subjects. 
Parameter ET RT CT 
RVFAC (%) 50 ± 10 [40:62] 50 ± 10 [42:60] 50 ± 10 [40:58] 
TAPSE 24 ± 3 [21:29] 24 ± 3 [22:26] 25 ± 2 [23:26] 
RVOT VTI 18 ± 3 [15:24] 20 ± 2 [19:21] 15 ± 3 [10:20] 
RVSV (ml) 104 ± 53 [78:164] 92 ± 33 [62:144] 99 ± 33 [42:149] 
RVSV (ml/[m2]1.5) 34 ± 15 [26:63] 29 ± 10 [21:49] 32 ± 11 [22:51] 
RVS’ cm/s 15 ± 1 [13:17] 15 ± 2 [13:18] 14 ± 2 [11:17] 
RVS’ ([cm/s]/cm) 1.7 ± 0.3 [1.1:2.3] 1.8 ± 0.3 [1.4:2.2] 1.7 ± 0.3 [1.3:2.3] 
RVE’ cm/s 15 ± 2 [13:19] 16 ± 3 [14:19] 14 ± 3 [9:17] 
RVE’ ([cm/s]/cm) 1.7 ± 0.3 [1.2:2.4] 1.7 ± 0.4 [0.5:2.8] 1.7 ± 0.4 [1.0:2.5] 
RVA’ cm/s 12 ± 2 [10:17] 12 ± 1 [9:14] 12 ± 2 [9:14] 
RVA’ ([cm/s]/cm) 1.5 ± 0.4 [0.9:2.4] 1.3 ± 0.4 [0.7:2.4] 1.4 ± 0.3 [0.7:2.0] 
Data are mean ± SD with [range]. 
TAPSE-tricuspid annular plane systolic excursion, RVOTVTI-RV out flow tract velocity time 
integral, RVS- RVS’-RV lateral wall peak systolic tissue velocity, RVE’-RV lateral wall peak 
early diastolic tissue velocity, RVA’-RV lateral wall peak late diastolic tissue velocity. RVS’, RV 
E’ and RVA’ were Scaled to RV length (RVS’/RVD3) ([cm/s]/ [cm]). 
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Table 5: STE-derived RV longitudinal ԑ and SR.  
 
Data are mean ± SD with [range]. 
ԑ-strain, SRS -strain rates in systole, SRE- strain rate in early diastole, SRA- strain rate in late 
diastole 
 
 
RV Parameters ET  RT CT 
Peak global RV ԑ (%) -26.9 ± 4.3 [-34.7:-
21.3] 
-27.4 ± 4.9 [-36.6:-
21.8]) 
-28.4 ± 2.7 [-37.0:-
25.0] 
Peak basal wall ԑ (%) -26.2 ± 3.4 [-32.9:-
20.7] 
-26.5 ± 3.2 [-32.6:-
20.7] 
-28.2 ± 3.0 [-34.8:-
24.5] 
Peak mid wall ԑ (%) -26.4 ± 5.2 [-33.2:-
20.4] 
-27.5 ±2.5 [-33.6:-
23.6] 
-28.4 ± 4.6 [-37.9:-
22.0] 
Peak apical wall ԑ 
(%) 
-30.7 ± 4.1 [-38.8: -
23.5] 
-31.3 ± 3.3 [-36.6:-
26.2] 
-32.6 ± 3.0 [-38.8:-
23.5] 
Base to apex ԑ 
gradient (%) 
-4.6 ± 2.5 [-9.4: -
0.8] 
-4.7 ± 2.5 [-8.3:-1.0] -4.4 ±2.9 [-9.1:-1.9] 
Peak global RV SRS 
(s-1)  
-1.4 ± 0.2 [-2.0:-1.1] -1.5 ± 0.3 [-2.1:-1.0] -1.5 ± 0.2 [-2.0:-1.2] 
Peak global RV SRE 
(s-1 ) 
1.2 ± 0.5 [1.1:2.8] 1.8 ± 0.5 [1.2:2.8] 1.9 ± 0.5 [1.2:2.8] 
Peak global RV SRA 
(s-1)  
1.1 ± 0.2 [0.8:1.6] 1.1 ± 0.3 [0.5:1.6] 1.0 ± 0.3 [0.5:1.4] 
